Interview with Nihal Aygun, CEO, Corena Turkey
Mrs Aygun, could you please introduce yourself to our readers and give us an overview of CORENA? I have an educational background in chemistry and a professional experience in several…
Address: 2545. Sokak Toyko Villalari No:14 Umitkoy / Yenimahalle / Ankara / TURKEY
2545. Sokak Toyko Villalari No:14 Umitkoy / Yenimahalle / Ankara / Turkey
Tel: +90 312 236 43 34
Web: http://www.corena.com.tr/
CORENA has been successfully serving to its clients worldwide since 1998 with an overall focus to help clients locate new areas of expansion within the marketplace, to implement best practices for achieving success and to achieve high growth levels in these areas of opportunity. With our extensive geographic coverage we are committed to consistently striving to deliver relevant tailored solutions,
Authenticity, happiness, passion, commitment and responsibility are the key words in the daily life of our company…
FIELD OF ACTIVITIES
INTERNATIONAL SALES
CLINICAL TRIALS
Weprovide governments, multilateral and procurement agencies, non-governmental organisations, charities, missionary groups, pharmaceutical wholesalers, hospitals and retail chemistsin 53 differentcountrieswithwiderangeof productssuch as:
PHARMACEUTICALS
OTC PRODUCTS
VACCINES
MEDICAL DEVICES
COSMETICS
DIET PRODUCTS
VETERINARIAN PRODUCTS
DIAGNOSTICS
CLINICAL TRIALS
CORENA dispatchesproductstoclinicaltrial centres across the worldwiththebestdeliveryconditonssuch as:
Cold chain and ambient supply chain
Fully tracked deliveries including temperature control
Specialized andExperienced Team
CORENA’S DIFFERENCE
With 15 yearsexperiece of sourcingquality- assuredandreliableproducts, wehavebeenabletobuildupstrong global supplierrelationship,andyou can alwaysdepend on thequality of CORENA’sproducts, BECAUSE WE DIFFER FROM THE OTHERS IN MANY ASPECTS SUCH AS:
OFFERINGS
LOGISTICS
SECURITY
LICENCES
CONFIDENTIALTY
EXPERIENCED AND SPECIALIZED TEAM
OUR OFFERINGS
Whereveryouare,operateorwork, our experienced multi-lingual team are able to source pharmaceuticals and other medical products for you in any quantity at any time and at any competitive price.
Weoffer awiderange of packagingoptionsincludingvalidatedboxesandmaterialsforcoldchainandhazardousitems.
Wearealsoquiteeffectivewiththeshipment of theorders. 90 % of yourproductsaredispatchedwithin 3-4 daysdays. As forthe life-savingmedicineswe do ourbesttosendthem on thesameday.
STORAGE
Temperature of theproducts is monitored and recorded periodically. The records of temperature are reviewed regularly.
Storage facilities arealwaysclean and free from litter, dust and pests.
Adequate precautions aretaken against spillage or breakage, attack by micro-organisms and cross contamination.
There is a system to ensure stock rotation (‘first in first out’) with regular and frequent checks that the system is operating correctly.
Products beyond their expiry date or shelf life are separated from usable stock and neither sold nor supplied.
Medicinal products with broken seals, damaged packaging, or suspected of possible contamination arewithdrawn from saleable stock, and if not immediately destroyed, they arekept in a clearly separated area in order not to be soldbe sold mistakenly, ortoavoidthecontamination o otherproducts.
LOGISTICS
CORENA will manage your shipment and ensure that your goods arrive in the best conditions at the right time and place, and with all correct documentation.
We offer:
• Delivery within 3-4 daysfor most products depending on destination
• Specialist packaging to ensure perfect condition on arrival including temperature sensitive, dangerous/hazardous and fragile
• Competitive freight alternatives around the world
COLD CHAIN
We frequently ship to over 53 countries and our specialist logistics team ensures deliveries go out on time from our fully licensed warehouse.
Cold chain deliveries:
CORENA has extensive experience in shipping temperature-sensitive goods across the globe using either refrigerated transport or insulated packaging.
We have full SOPs to cover all elements of temperature-sensitive transport and these are available for inspection by our clients. CORENA uses temperature boxes and tracks all shipments using temperature loggers. We are, of course, willing to abide by any trial protocols and use differing technologies if necessary.
Mrs Aygun, could you please introduce yourself to our readers and give us an overview of CORENA? I have an educational background in chemistry and a professional experience in several…
Consumer healthcare products manufacturer Winalite is working to penetrate the Turkish market, but with regulations complicating bringing their portfolio from China, general manager Arafat Yadigar is looking to develop a…
Ozgur Tomruk, J&J’s Managing Director for Global Surgery talks about Turkey’s importance for the company, the priorities they have set, J&J’s commitment to quality and his ambition for the company’s…
Nil Tunaşar, managing partner of Transorient, discusses significance of tracking performance metrics among 3PL providers, the organization’s technology overhaul, and also highlights the type of logistics solutions encompassed under Transorient’s…
Matthias Diewald (MD) and Asli Volkan (AV) elaborate on HELM Kimya’s longstanding presence within Turkey and the type of market opportunities available for co-development and contract manufacturing. They also explain the…
Haluk Ataoglu, academic turned founder of Matriks Biotek®, talks about his aspirations for his company and the Turkish R&D landscape as well as how to penetrate the global pharmaceutical market…
Prof. Dr. Murat Özgören, the architect behind the ambitious BioIzmir project, talks about its potential and how it intends to educate new talent to address critical future needs of the…
BMS Turkey’s new general manager discusses Opdivo (nivolumab) their revolutionary new product for squamous non-small cell lung cancer, their registry of 1200 patients in Turkey with melanoma, potential developments in pharmaceutical…
Multinational R&D investment in Turkey, particularly investment in clinical trials, has been quite limited relative to the size of the Turkish pharmaceutical market. Turkish R&D spending amounted to just 0.95…
Over the past six years, Turkey has consistently lowered its drugs prices and guided its companies to greater efficiency. “Reference prices in Turkey are constructed from the lowest price in…
In the coming years, Turkey plans to prioritize R&D initiatives, health studies and medical innovation: that’s the core message Minister of Health Mehmet Müezzinoğlu gave PharmaBoardroom. This is the beginning…
Recep Altekin, the general manager of MT Sağlik – market leader in Turkey for blood glucose monitoring systems and diabetes test strips by volume – tells PharmaBoardroom about his company’s impact…
AstraZeneca’s Country President for Turkey discusses their efforts to build scientific leadership in Turkey in line with their global strategy and her hopes for the market access and public-private partnership…
See our Cookie Privacy Policy Here